VIX +23%
Reportedly UK officials to block €5.0B sale of RWE oil and gas unit Dea to a Russian investor - financial press
BASF is said to be a potential alternative acquirer of the RWE assets
{SHP LN Equity QMC <GO>}
*ABBVIE SAID CLOSE TO DROPPING SHIRE BID AS TAX RULES CHANGE
*BARCELONA AIRPORT UNDER QUARANTINE AS 6 PASSENGERS CONFIRMED POSITIVE FOR EBOLA VIRUS
+------------------------------------------------------------------------------+
BN 10/15 13:49 Hall Commodities Hedge Fund Shutting Down After Poor Performance
+------------------------------------------------------------------------------+
Hall Commodities Hedge Fund Shutting Down After Poor Performance 2014-10-15 13:51:16.150 GMT
By Saijel Kishan Oct. 15 (Bloomberg) -- Hall Commodities LLP, a London- based hedge fund set up by Tony Hall and Arno Pilz, told clients it’s shutting at the end of the month citing poor performance. * Hall told clients in an Oct. 9 letter, a copy of which was obtained by Bloomberg * The firm’s main fund lost 11 percent this year through September
Story Link:NSN NDHNQZ6S972E<GO>
For Related News and Information: First Word scrolling panel: FIRST<GO> First Word newswire: NH BFW<GO>
To contact the reporter on this story: Saijel Kishan in New York at +1-212-617-6662 or skishan@bloomberg.net To contact the editors responsible for this story: Brian Swint at +44-20-7073-3444 or bswint@bloomberg.net
Gapping down
In reaction to disappointing earnings/guidance: LLTC -3.7%, KEY -2.8%, INTC -1.1%, KTCC -1.1%
M&A news: SHPG -25.9% (notice to Shire Of AbbVie (ABBV) Board intention to reconsider recommendation), ABBV -3.9% (Announcement of notice to Shire Of AbbVie (ABBV) Board intention to reconsider recommendation), QCOM -0.5% (Qualcomm (QCOM) to acquire CSR for ~$2.5 bln)
Select EU related names showing weakness: SAN -3.5%, ALU -3.2%, BCS -2.7%, ALV -2.6%, NOK -2.5%, UBS -1.8%
Select metals/mining stocks trading lower: GFI -2.7%, RIO -2.3%, CDE -2.1%, MT -2.1%, VALE -1.8%, GOLD -1.2%, GDX -0.8%
Other news: CNET -10.3% (following 60%+ move higher yesterday), GWPH -4.9% (cont weakness), STAG -4.3% (announces public offering of 5 mln shares of common stock), NSPH -4.2% (following yesterday's 40% decline), STO -3.9% (president and CEO Helge Lund resigns), SNN -3.6% (likely attributed to tax inversion rules and fall out from SHPG/ABBV merger news), AZN -2.6% (likely attributed to tax inversion rules and fall out from SHPG/ABBV merger news), CUBE -2.2% (announces public offering of 6.5 mln common shares of beneficial interest), ESPR -1.4% (announces proposed public offering of $85 mln of common stock)
Analyst comments: RIG -2.2% (initiated with a Sell at ISI Group), OXY -0.6% (downgraded to Neutral from Outperform at Credit Suisse)
In reaction to disappointing earnings/guidance: LLTC -3.7%, KEY -2.8%, INTC -1.1%, KTCC -1.1%
M&A news: SHPG -25.9% (notice to Shire Of AbbVie (ABBV) Board intention to reconsider recommendation), ABBV -3.9% (Announcement of notice to Shire Of AbbVie (ABBV) Board intention to reconsider recommendation), QCOM -0.5% (Qualcomm (QCOM) to acquire CSR for ~$2.5 bln)
Select EU related names showing weakness: SAN -3.5%, ALU -3.2%, BCS -2.7%, ALV -2.6%, NOK -2.5%, UBS -1.8%
Select metals/mining stocks trading lower: GFI -2.7%, RIO -2.3%, CDE -2.1%, MT -2.1%, VALE -1.8%, GOLD -1.2%, GDX -0.8%
Other news: CNET -10.3% (following 60%+ move higher yesterday), GWPH -4.9% (cont weakness), STAG -4.3% (announces public offering of 5 mln shares of common stock), NSPH -4.2% (following yesterday's 40% decline), STO -3.9% (president and CEO Helge Lund resigns), SNN -3.6% (likely attributed to tax inversion rules and fall out from SHPG/ABBV merger news), AZN -2.6% (likely attributed to tax inversion rules and fall out from SHPG/ABBV merger news), CUBE -2.2% (announces public offering of 6.5 mln common shares of beneficial interest), ESPR -1.4% (announces proposed public offering of $85 mln of common stock)
Analyst comments: RIG -2.2% (initiated with a Sell at ISI Group), OXY -0.6% (downgraded to Neutral from Outperform at Credit Suisse)
*LUNDBECK MAY BID ON GLAXO’S OLDER PRODUCTS: REUTERS
2014-10-15 12:54:00.694 GMT
--RONALD DAY
-0- Oct/15/2014 12:54 GMT
2014-10-15 12:54:00.694 GMT
--RONALD DAY
-0- Oct/15/2014 12:54 GMT
CNBC's Faber: Breakup of AbbVie/Shire deal is pressuring broader markets
- @davidfaber: "Shire deal potential collapse is pressuring broader market.Filings have Paulson at 27.8m shares, Magnetar 16.5m,Elliott 13.2m #arbageddon"
Gapping up
In reaction to strong earnings/guidance: SURG +4.7%, MTG +2.3%, CSX +1.8%, HPQ +1.8%, NHTC +1.5%, BLK +1.4%, BAC +0.7%, PNC +0.5%, .
M&A news: CSRE +30.5% (Qualcomm (QCOM) to acquire CSR for ~$2.5 bln)
Select Ebola related names showing strength: APT +24.3%, LAKE +16.2%, IBIO +10%, HEB +6.3%, NLNK +6.1%, CERS +3.7%, CMRX +3.3%, SRPT +3.1%, TKMR +3%, INO +2.1%, NNVC +1.4%
Other news: ANN +8.2% (Golden Gate Capital files amended 13D with Confidentiality Agreement dated today Oct 14), NAVB +7.3% (FDA approves expanded use of Navidea's Lymphoseek for lymphatic mapping in solid tumors), GTAT +4.9% (Apple (AAPL) wants to secretly challenge GTAT bankruptcy, according to reports), MPO +4.3% (provides hedging update; 1212K barrels/day through 2Q15 at avg. ~$90/bbl), STRP +1.2% (after 18% move higher on earnings yesterday), SSRI +1.1% (analyst tour at Marigold highlights life of mine plan and exploration results), AMD +1.1% (in symp with INTC earnings), CCL +0.9% (Carnival and largest Chinese Shipyard sign Memo of Understanding aimed at growing the cruise industry in China), .
Analyst comments: PTEN +2% (initiated with a Buy at Citigroup), UNFI +1.9% (upgraded to Overweight from Neutral at Piper Jaffray), EXXI +1.5% (upgraded to Buy from Neutral at Global Hunter Securities), SWIR +1.1% (initiated with a Outperform at Northland Capital), CBS +1.1% (upgraded to Buy from Neutral at Citigroup), AMAT +0.8% (upgraded to Buy from Neutral at BofA/Merrill), RAX+0.6% (upgraded to Outperform from Sell at Credit Agricole), HST +0.5% (upgraded to Overweight from Equal Weight at Barclays)
In reaction to strong earnings/guidance: SURG +4.7%, MTG +2.3%, CSX +1.8%, HPQ +1.8%, NHTC +1.5%, BLK +1.4%, BAC +0.7%, PNC +0.5%, .
M&A news: CSRE +30.5% (Qualcomm (QCOM) to acquire CSR for ~$2.5 bln)
Select Ebola related names showing strength: APT +24.3%, LAKE +16.2%, IBIO +10%, HEB +6.3%, NLNK +6.1%, CERS +3.7%, CMRX +3.3%, SRPT +3.1%, TKMR +3%, INO +2.1%, NNVC +1.4%
Other news: ANN +8.2% (Golden Gate Capital files amended 13D with Confidentiality Agreement dated today Oct 14), NAVB +7.3% (FDA approves expanded use of Navidea's Lymphoseek for lymphatic mapping in solid tumors), GTAT +4.9% (Apple (AAPL) wants to secretly challenge GTAT bankruptcy, according to reports), MPO +4.3% (provides hedging update; 1212K barrels/day through 2Q15 at avg. ~$90/bbl), STRP +1.2% (after 18% move higher on earnings yesterday), SSRI +1.1% (analyst tour at Marigold highlights life of mine plan and exploration results), AMD +1.1% (in symp with INTC earnings), CCL +0.9% (Carnival and largest Chinese Shipyard sign Memo of Understanding aimed at growing the cruise industry in China), .
Analyst comments: PTEN +2% (initiated with a Buy at Citigroup), UNFI +1.9% (upgraded to Overweight from Neutral at Piper Jaffray), EXXI +1.5% (upgraded to Buy from Neutral at Global Hunter Securities), SWIR +1.1% (initiated with a Outperform at Northland Capital), CBS +1.1% (upgraded to Buy from Neutral at Citigroup), AMAT +0.8% (upgraded to Buy from Neutral at BofA/Merrill), RAX+0.6% (upgraded to Outperform from Sell at Credit Agricole), HST +0.5% (upgraded to Overweight from Equal Weight at Barclays)